All the news

Scientific results

Tuesday 23 April 2013

Theranexus: boosting the effectiveness of psychotropics

CEA The start-up Theranexus, a spin-off from the CEA, was launched on March 19. Its objective: to propose an adjuvant treatment [1] to be given in addition to psychotropic [2] medications that will augment their effectiveness or, in diminished doses, reduce their undesirable effects. Theranexus will be engaged in a large part of the product chain, from preclinical research to phase 2 clinical trials.